» Authors » Andreas G Wibmer

Andreas G Wibmer

Explore the profile of Andreas G Wibmer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 719
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Eljalby M, Huang X, Becher T, Wibmer A, Jiang C, Vaughan R, et al.
Am J Physiol Endocrinol Metab . 2022 Dec; 324(2):E144-E153. PMID: 36576355
Although brown fat is strongly associated with a constellation of cardiometabolic benefits in animal models and humans, it has also been tied to cancer cachexia. In humans, cancer-associated cachexia increases...
2.
Wibmer A, Dinh P, Travis L, Chen C, Bromberg M, Zheng J, et al.
JNCI Cancer Spectr . 2022 Jul; 6(4). PMID: 35801305
Background: It is unknown how body fat distribution modulates the cardiometabolic risk of testicular cancer survivors after cisplatin-based chemotherapy. Methods: For 455 patients enrolled in the Platinum Study at Memorial...
3.
Chakraborty G, Nandakumar S, Hirani R, Nguyen B, Stopsack K, Kreitzer C, et al.
Clin Cancer Res . 2022 Jun; 28(16):3603-3617. PMID: 35670774
Purpose: Oncogenic alterations of the PI3K/AKT pathway occur in >40% of patients with metastatic castration-resistant prostate cancer, predominantly via PTEN loss. The significance of other PI3K pathway components in prostate...
4.
Wibmer A, Lefkowitz R, Lakhman Y, Chaim J, Nikolovski I, Sala E, et al.
Clin Genitourin Cancer . 2022 May; 20(4):319-325. PMID: 35618599
Introduction/background: Magnetic resonance imaging (MRI) misses a proportion of "clinically significant" prostate cancers (csPC) as defined by histopathology criteria. The aim of this study was to analyze whether long-term oncologic...
5.
Gorovets D, Wibmer A, Moore A, Lobaugh S, Zhang Z, Kollmeier M, et al.
Eur Urol Oncol . 2022 Mar; 6(3):275-281. PMID: 35307323
Background: A positive post-treatment prostate biopsy following definitive radiotherapy carries significant prognostic implications. Objective: To determine whether local recurrences after prostate stereotactic body radiation therapy (SBRT) are associated with the...
6.
Wibmer A, Nikolovski I, Chaim J, Lakhman Y, Lefkowitz R, Sala E, et al.
Radiology . 2021 Dec; 302(3):595-602. PMID: 34931855
Background It is unknown how the imperfect accuracy of MRI for local staging of prostate cancer relates to oncologic outcomes. Purpose To analyze how staging discordances between MRI and histopathologic...
7.
Woo S, Suh C, Wibmer A, Becker A, Teo M, Gonen M, et al.
Clin Genitourin Cancer . 2021 Dec; 20(1):69-79. PMID: 34903480
Introduction/background: Radiographic progression-free survival (rPFS) based on Prostate Cancer Working Group 2 (PCWG2) has been increasingly used as a meaningful imaging-based intermediate endpoint (IBIE) for overall survival (OS) in patients...
8.
Wibmer A, Becher T, Eljalby M, Crane A, Andrieu P, Jiang C, et al.
Cell Rep Med . 2021 Aug; 2(7):100332. PMID: 34337558
The association of brown adipose tissue (BAT) and body fat distribution and their combined effects on metabolic health in humans remains unknown. Here, we retrospectively identify individuals with and without...
9.
Woo S, Ghafoor S, Becker A, Han S, Wibmer A, Hricak H, et al.
Eur J Hybrid Imaging . 2021 Jun; 4(1):16. PMID: 34191215
Purpose: Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has shown promise for detecting nodal and distant prostate cancer (PCa) metastases. However, its performance for local tumor staging is not as...
10.
Wibmer A, Kattan M, Alessandrino F, Baur A, Boesen L, Franco F, et al.
Cancers (Basel) . 2021 Jun; 13(11). PMID: 34071842
Background: To develop an international, multi-site nomogram for side-specific prediction of extraprostatic extension (EPE) of prostate cancer based on clinical, biopsy, and magnetic resonance imaging- (MRI) derived data. Methods: Ten...